Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck

Human Molecular Genetics

Volumn 25, Issue 5, 2016, Pages 1031-1041

  Wilson, Ian J ^a   Carling, Phillipa J ^a,b   Alston, Charlotte L ^a,b   Floros, Vasileios I ^c,d   Pyle, Angela ^a,b   Hudson, Gavin ^a,b   Sallevelt, Suzanne C E H ^e   Lamperti, Costanza ^f   Carelli, Valerio ^g,h   Bindoff, Laurence A ^i,j   Samuels, David C ^k   Wonnapinij, Passorn ^l   Zeviani, Massimo ^c,f   Taylor, Robert W ^a,b   Smeets, Hubert J M ^e   Horvath, Rita ^a,b   Chinnery, Patrick F ^b,c,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

^g BELLARIA HOSPITAL   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j UNIVERSITY OF BERGEN   (Norway)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l KASETSART UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ALLELE; ARTICLE; ASCERTAINMENT BIAS; BOTTLENECK POPULATION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HETEROPLASMY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BAYES THEOREM; BIOLOGICAL MODEL; CHILD; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETICS; PATHOLOGY; PEDIGREE; POINT MUTATION; PUBLISHING;

BAYES THEOREM; CHILD; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INHERITANCE PATTERNS; MITOCHONDRIAL DISEASES; MODELS, GENETIC; PEDIGREE; PHENOTYPE; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PUBLICATION BIAS;

EID: 84962828809     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv626     Document Type: Article

References (105)

1. Vafai, S.B. and Mootha, V.K. (2013) Medicine. A common pathway for a rare disease? Science, 342, 1453-1454.
2. Gorman, G.S., Schaefer, A.M., Ng, Y. et al. (2015) Prevalence of nuclear and mtDNA mutations related to adult mitochondrial disease. Ann. Neurol., 77, 753-759.
3. DiMauro, S., Schon, E.A., Carelli, V. and Hirano, M. (2013) The clinical maze of mitochondrial neurology. Nat. Rev. Neurol., 9, 429-444.
4. Upholt, W.B. and Dawid, I.B. (1977) Mapping of mitochondrial DNA of individual sheep and goats: rapid evolution in the D loop region. Cell, 11, 571-583.
5. Olivo, P.D., Van deWalle, M.J., Laipis, P.J. andHauswirth, W.W. (1983) Nucleotide sequence evidence for rapid genotypic shifts in the bovine mitochondrial DNA D-loop. Nature, 306, 400-402.
6. Cree, L.M., Samuels, D.C., de Sousa Lopes, S.C. et al. (2008) A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Nat. Genet., 40, 249-254.
7. Wai, T., Teoli, D. and Shoubridge, E.A. (2008) The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat. Genet., 40, 1484-1488.
8. Howell, N., Halvorson, S., Kubacka, I., McCullough, D.A., Bindoff, L.A. and Turnbull, D.M. (1992) Mitochondrial gene segregation in mammals: is the bottleneck always narrow? Hum. Genet., 90, 117-120.
9. Chinnery, P.F., Thorburn, D.R., Samuels, D.C. et al. (2000) The inheritance of mtDNA heteroplasmy: random drift, selection or both? Trends Genet., 16, 500-505.
10. Uusimaa, J., Moilanen, J.S., Vainionpaa, L. et al. (2007) Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann. Neurol., 62, 278-287.
11. Hellebrekers, D.M., Wolfe, R., Hendrickx, A.T. et al. (2012) PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. Hum. Reprod., update 18, 341-349.
12. Brown, D.T., Samuels, D.C., Michael, E.M., Turnbull, D.M. and Chinnery, P.F. (2001) Random genetic drift determines the level of mutant mitochondrial DNA in human primary oocytes. Am. J. Hum. Genet., 68, 553-536.
13. Wright, S. (1969) Evolution and the Genetics of Populations. University of Chicago Press, Chicago.
14. Rajasimha, H.K., Chinnery, P.F. and Samuels, D.C. (2008) Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A->G mutation in blood. Am. J. Hum. Genet., 82, 333-343.
15. Plummer, M. (2003) JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling. In Proceedings of the 3rd InternationalWorkshop on Distributed Statistical Computing. Technische Universit at Wien, Vol. 124, p. 125.
16. Rebolledo-Jaramillo, B., Su, M.S., Stoler, N. et al. (2014) Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA. Proc. Natl Acad. Sci. USA, 111, 15474-15479.
17. Blok, R.B., Gook, D.A., Thorburn, D.R. and Dahl, H.H. (1997) Skewed segregation of the mtDNA nt 8993 (T to G) mutation in human oocytes. Am. J. Hum. Genet., 60, 1495-1501.
18. White, S.L., Collins, V.A., Woolfe, R. et al. (1999) Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am. J. Hum. Genet., 65, 474-482.
19. Larsson, N.G., Tulinius, M.H., Holme, E. et al. (1992) Segregation and manifestations of the mtDNA tRNA(Lys) A->G (8344) mutation ofmyoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am. J. Hum. Genet., 51, 1201-1212.
20. Ciafaloni, E., Ricci, E., Shanske, S. et al. (1992) MELAS: clinical features, biochemistry, and molecular genetics. Ann. Neurol., 31, 391-398.
21. Elliott, H.R., Samuels, D.C., Eden, J.A., Relton, C.L. and Chinnery, P.F. (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am. J. Hum. Genet., 83, 254-460.
22. Chinnery, P.F., Johnson, M.A., Wardell, T.M. et al. (2000) Epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol., 48, 188-193.
23. Hammans, S.R., Sweeney, M.G., Brockington, M. et al. (1993) The mitochondrial DNA transfer RNA(Lys)A->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain, 116, 617-632.
24. Uziel, G., Moroni, I., Lamantea, E. et al. (1997)Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J. Neurol. Neurosurg. Psychiatry, 63, 16-22.
25. Pfeffer, G., Blakely, E.L., Alston, C.L. et al. (2012) Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations. J. Neurol. Neurosurg. Psychiatry, 83, 883-886.
26. Wonnapinij, P., Chinnery, P.F. and Samuels, D.C. (2010) Previous estimates of mitochondrial DNA mutation level variance did not account for sampling error: comparing the mtDNA genetic bottleneck in mice and humans. Am. J. Hum. Genet., 86, 540-550.
27. Moreno-Loshuertos, R., Acin-Perez, R., Fernandez-Silva, P. et al. (2006) Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat. Genet., 38, 1261-1268.
28. Gomez-Duran, A., Pacheu-Grau, D., Lopez-Gallardo, E. et al. (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet., 19, 3343-3353.
29. Monnot, S., Samuels, D.C., Hesters, L. et al. (2013) Mutation dependance of the mitochondrial DNA copy number in the first stages of human embryogenesis. Hum. Mol. Genet., 22, 1867-1872.
30. Pello, R., Martin, M.A., Carelli, V. et al. (2008) Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum. Mol. Genet., 17, 4001-4011.
31. Stewart, J.B. and Larsson, N.G. (2014) Keeping mtDNA in shape between generations. PLoS Genet., 10, e1004670.
32. Solignac, M., Monnerot, M. and Mounolou, J.C. (1983) Mitochondrial DNA heteroplasmy in Drosophila mauritiana. Proc. Natl Acad. Sci. USA, 80, 6942-6946.
33. Payne, B.A., Wilson, I.J., Yu-Wai-Man, P. et al. (2013) Universal heteroplasmy of human mitochondrial DNA. Hum. Mol. Genet., 22, 384-390.
34. Hudson, G., Gomez-Duran, A., Wilson, I.J. and Chinnery, P.F. (2014) Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases. PLoS Genet., 10, e1004369.
35. Carelli, V., Ghelli, A., Ratta, M. et al. (1997) Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology, 48, 1623-1632.
36. Chuenkongkaew, W.L., Suphavilai, R., Vaeusorn, L., Phasukkijwatana, N., Lertrit, P. and Suktitipat, B. (2005) Proportion of 11778 mutant mitochondrial DNA and clinical expression in a thai population with leber hereditary optic neuropathy. J. Neuro-Ophthalmol., 25, 173-175.
37. Harding, A.E., Sweeney, M.G., Govan, G.G. and Riordan-Eva, P. (1995) Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am. J. Hum. Genet., 57, 77-86.
38. Holt, I.J., Miller, D.H. and Harding, A.E. (1989) Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J. Med. Genet., 26, 739-743.
39. Howell, N., Xu, M., Halvorson, S., Bodis-Wollner, I. and Sherman, J. (1994) A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. Am. J. Hum. Genet., 55, 203-206.
40. Juvonen, V., Nikoskelainen, E., Lamminen, T., Penttinen, M., Aula, P. and Savontaus, M.L. (1997) Tissue distribution of the ND4/11778 mutation in heteroplasmic lineages with Leber hereditary optic neuropathy. Hum. Mutat., 9, 412-417.
41. Phasukkijwatana, N., Chuenkongkaew, W.L., Suphavilai, R., Luangtrakool, K., Kunhapan, B. and Lertrit, P. (2006) Transmission of heteroplasmic G11778A in extensive pedigrees of Thai Leber hereditary optic neuropathy. J. Hum. Genet., 51, 1110-1117.
42. Simon, D.K., Pulst, S.M., Sutton, J.P., Browne, S.E., Beal, M.F. and Johns, D.R. (1999) Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology, 53, 1787-1793.
43. Sweeney, M.G., Davis, M.B., Lashwood, A., Brockington, M., Toscano, A. and Harding, A.E. (1992) Evidence against an X-linked locus close to DXS7 determining visual loss susceptibility in British and Italian families with Leber hereditary optic neuropathy. Am. J. Hum. Genet., 51, 741-748.
44. Tanaka, A., Kiyosawa, M., Mashima, Y. and Tokoro, T. (1998) A family with Leber's hereditary optic neuropathy with mitochondrial DNA heteroplasmy related to disease expression. J Neuro-Ophthalmol., 18, 81-83.
45. Zhu, D.P., Economou, E.P., Antonarakis, S.E. and Maumenee, I.H. (1992) Mitochondrial DNA mutation and heteroplasmy in type I Leber hereditary optic neuropathy. Am. J. Med. Genet., 42, 17317-9.
46. Black, G.C., Morten, K., Laborde, A. and Poulton, J. (1996) Leber's hereditary optic neuropathy: heteroplasmy is likely to be significant in the expression of LHON in families with the 3460 ND1 mutation. Brit. J. Ophthalmol., 80, 915-917.
47. Ghosh, S.S., Fahy, E., Bodis-Wollner, I., Sherman, J. and Howell, N. (1996) Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing. Am. J. Hum. Genet., 58, 325-334.
48. Howell, N., Bindoff, L.A., McCullough, D.A. et al. (1991) Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am. J. Hum. Genet., 49, 939-950.
49. Howell, N., McCullough, D. and Bodis-Wollner, I. (1992) Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy. Am. J. Hum. Genet., 50, 443-446.
50. Kaplanova, V., Zeman, J., Hansikova, H. et al. (2004) Segregation pattern and biochemical effect of the G3460A mtDNA mutation in 27 members of LHON family. J. Neurol. Sci., 223, 149-155.
51. Volod'ko, N.V., L'Vova, M.A., Starikovskaia, E.B. et al. (2006) Spectrum of pathogenic mtDNA mutations in Leber hereditary optic neuropathy families from Siberia. Genetika, 42, 89-97.
52. Campos, Y., Esteban, J., Cabello, A. and Arenas, J. (1994) Genetic analysis of one family with myoclonic epilepsy and ragged-red fibers (MERRF). Muscle Nerve, 17, 1229-1231.
53. Gamez, J., Playan, A., Andreu, A.L. et al. (1998) Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology, 51, 258-260.
54. Hammans, S.R., Sweeney, M.G., Hanna, M.G., Brockington, M., Morgan-Hughes, J.A. and Harding, A.E. (1995) The mitochondrial DNA transfer RNALeu(UUR) A->G(3243) mutation. A clinical and genetic study. Brain, 118(Pt 3), 721-734.
55. Howell, N., Kubacka, I., Smith, R., Frerman, F., Parks, J.K. and Parker, W.D. Jr (1996) Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology, 46, 219-222.
56. Munoz-Malaga, A., Bautista, J., Salazar, J.A. et al. (2000) Lipomatosis, proximal myopathy, and the mitochondrial 8344 mutation. A lipid storage myopathy? Muscle Nerve, 23, 538-542.
57. Piccolo, G., Focher, F., Verri, A. et al. (1993) Myoclonus epilepsy and ragged-red fibers: blood mitochondrial DNA heteroplasmy in affected and asymptomatic members of a family. Acta. Neurol. Scand., 88, 406-409.
58. Seibel, P., Flierl, A., Kottlors, M. and Reichmann, H. (1994) A rapid and sensitive PCR screening method for point mutations associated with mitochondrial encephalomyopathies. Biochem. Biophys. Res. Commun., 200, 938-942.
59. Silvestri, G., Ciafaloni, E., Santorelli, F.M. et al. (1993) Clinical features associated with the A->G transition at nucleotide 8344 ofmtDNA ('MERRF mutation'). Neurology, 43, 1200-1206.
60. Traff, J., Holme, E., Ekbom, K. and Nilsson, B.Y. (1995) Ekbom's syndrome of photomyoclonus, cerebellar ataxia and cervical lipoma is associated with the tRNA(Lys) A8344G mutation in mitochondrial DNA. Acta Neurol. Scand., 92, 394-397.
61. van de Glind, G., de Vries, M., Rodenburg, R., Hol, F., Smeitink, J. and Morava, E. (2007) Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation. Eur. J. Paed. Neurol., 11, 243-246.
62. Wong, L.J., Wong, H. and Liu, A. (2002) Intergenerational transmission of pathogenic heteroplasmic mitochondrial DNA. Genet. Med., 4, 78-83.
63. Bartley, J., Senadheera, D., Park, P., Brar, H., D, A. and Wong, L. (1996) Prenatal diagnosis of T8993G mitochondrial DNA point mutation in amniocytes by heteroplasmy detection. Am. J. Hum. Genet., 59.
64. Ciafaloni, E., Santorelli, F.M., Shanske, S. et al. (1993) Maternally inherited Leigh syndrome. J. Pediatr., 122, 419-422.
65. Degoul, F., Diry, M., Rodriguez, D. et al. (1995) Clinical, biochemical, and molecular analysis of a maternally inherited case of Leigh syndrome (MILS) associated with the mtDNA T8993G point mutation. J. Inher. Met. Dis., 18, 682-688.
66. Enns, G.M., Bai, R.K., Beck, A.E. andWong, L.J. (2006) Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load. Mol. Genet. Metab., 88, 364-371.
67. Ferlin, T., Landrieu, P., Rambaud, C. et al. (1997) Segregation of the G8993 mutant mitochondrial DNA through generations and embryonic tissues in a family at risk of Leigh syndrome. J. Pediatr., 131, 447-449.
68. Fryer, A., Appleton, R., Sweeney, M.G., Rosenbloom, L. and Harding, A.E. (1994) Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including 'cerebral palsy'. Arch. Dis. Childhood, 71, 419-422.
69. Holt, I.J., Harding, A.E., Petty, R.K. and Morgan-Hughes, J.A. (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet., 46, 428-433.
70. Houstek, J., Klement, P., Hermanska, J. et al. (1995) Altered properties of mitochondrial ATP-synthase in patients with a T->G mutation in the ATPase 6 (subunit a) gene at position 8993 of mtDNA. Biochim. Biophys. Acta, 1271, 349-357.
71. Lodi, R., Montagna, P., Iotti, S. et al. (1994) Brain and muscle energy metabolism studied in vivo by 31P-magnetic resonance spectroscopy in NARP syndrome. J. Neurol. Neurosurg. Psychiatry, 57, 1492-1496.
72. Mak, S.C., Chi, C.S., Liu, C.Y., Pang, C.Y. and Wei, Y.H. (1996) Leigh syndrome associated with mitochondrial DNA8993 T->G mutation and ragged-red fibers. Pediatr. Neurol., 15, 72-75.
73. Makela-Bengs, P., Suomalainen, A., Majander, A. et al. (1995) Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatric Res., 37, 634-639.
74. Mkaouar-Rebai, E., Chaari, W., Younes, S., Bousoffara, R., Sfar, M.T. and Fakhfakh, F. (2009) Maternally inherited Leigh syndrome: T8993G mutation in a Tunisian family. Pediatr. Neurol., 40, 437-442.
75. Pastores, G.M., Santorelli, F.M., Shanske, S. et al. (1994) Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G). Am. J. Med. Genet., 50, 265-271.
76. Porto, F.B., Mack, G., Sterboul, M.J. et al. (2001) Isolated lateonset cone-rod dystrophy revealing a familial neurogenic muscleweakness, ataxia, and retinitis pigmentosa syndrome with the T8993G mitochondrial mutation. Am. J. Ophthalmol., 132, 935-937.
77. Puddu, P., Barboni, P., Mantovani, V. et al. (1993) Retinitis pigmentosa, ataxia, and mental retardation associated with mitochondrial DNA mutation in an Italian family. Brit. J. Ophthalmol., 77, 84-88.
78. Sakuta, R., Goto, Y., Horai, S. et al. (1992) Mitochondrial DNA mutation and Leigh's syndrome. Ann. Neurol., 32, 597-598.
79. Santorelli, F.M., Shanske, S., Macaya, A., DeVivo, D.C. and Di-Mauro, S. (1993) The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann. Neurol., 34, 827-834.
80. Shoffner, J.M., Fernhoff, P.M., Krawiecki, N.S. et al. (1992) Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology, 42, 2168-2174.
81. Steffann, J., Gigarel, N., Corcos, J. et al. (2007) Stability of the m.8993T->G mtDNAmutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome. J. Med. Genet., 44, 664-669.
82. Tatuch, Y., Christodoulou, J., Feigenbaum, A. et al. (1992) Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet., 50, 852-858.
83. Tulinius, M.H., Houshmand, M., Larsson, N.G. et al. (1995) De novo mutation in the mitochondrial ATP synthase subunit 6 gene (T8993G) with rapid segregation resulting in Leigh syndrome in the offspring. Hum. Genet., 96, 290-294.
84. White, S.L., Shanske, S., McGill, J.J. et al. (1999) Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue-or age-related variation. J. Inher. Metab. Dis., 22, 899-914.
85. Cervin, C., Liljestrom, B., Tuomi, T. et al. (2004) Cosegregation of MIDD and MODY in a pedigree: functional and clinical consequences. Diabetes, 53, 1894-1899.
86. Chinnery, P.F., Zwijnenburg, P.J., Walker, M. et al. (1999) Nonrandom tissue distribution of mutant mtDNA. Am. J. Med. Genet., 85, 498-501.
87. Chou, Y.J., Ou, C.Y., Hsu, T.Y. et al. (2004) Prenatal diagnosis of a fetus harboring an intermediate load of the A3243G mtDNA mutation in a maternal carrier diagnosed with MELAS syndrome. Prenatal Diagn., 24, 367-370.
88. Dubeau, F., De Stefano, N., Zifkin, B.G., Arnold, D.L. and Shoubridge, E.A. (2000) Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann. Neurol., 47, 179-185.
89. Fabrizi, G.M., Cardaioli, E., Grieco, G.S. et al. (1996) The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome. J. Neurol. Neurosurg. Psychiatry, 61, 47-51.
90. Hotta, O., Inoue, C.N., Miyabayashi, S., Furuta, T., Takeuchi, A. and Taguma, Y. (2001) Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int., 59, 1236-1243.
91. Huang, C.C., Chen, R.S., Chen, C.M. et al. (1994) MELAS syndrome with mitochondrial tRNA(Leu(UUR)) gene mutation in a Chinese family. J.Neurol. Neurosurg. Psychiatry, 57, 586-589.
92. Huang, C.C., Chen, R.S., Chu, N.S., Pang, C.Y. and Wei, Y.H. (1996) Random mitotic segregation of mitochondrial DNA in MELAS syndrome. Acta Neurol. Scand., 93, 198-202.
93. Iwanishi, M., Obata, T., Yamada, S. et al. (1995) Clinical and laboratory characteristics in the families with diabetes and a mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes Res. Clin. Pract., 29, 75-82.
94. Jansen, J.J., Maassen, J.A., van derWoude, F.J. et al. (1997) Mutation in mitochondrial tRNA(Leu(UUR)) gene associated with progressive kidney disease. J. Am. Soc. Nephrol. JASN, 8, 1118-1124.
95. Ko, C.H., Lam, C.W., Tse, P.W., Kong, C.K., Chan, A.K. and Wong, L.J. (2001) De novo mutation in the mitochondrial tRNALeu(UUR) gene (A3243G) with rapid segregation resulting in MELAS in the offspring. J. Paedr. Child Health, 37, 87-90.
96. Lien, L.M., Lee, H.C., Wang, K.L., Chiu, J.C., Chiu, H.C. and Wei, Y.H. (2001) Involvement of nervous system in maternally inherited diabetes and deafness (MIDD) with the A3243G mutation of mitochondrial DNA. Acta Neurol. Scand., 103, 159-165.
97. Liou, C.W., Huang, C.C., Chee, E.C. et al. (1994) MELAS syndrome: correlation between clinical features and molecular genetic analysis. Acta Neurol. Scand., 90, 354-359.
98. Lu, C.Y., Tso, D.J., Yang, T., Jong, Y.J. andWei, Y.H. (2002) Detection of DNA mutations associated with mitochondrial diseases by Agilent 2100 bioanalyzer. Clin. Chim. Acta, 318, 97-105.
99. Martinuzzi, A., Bartolomei, L., Carrozzo, R. et al. (1992) Correlation between clinical and molecular features in two MELAS families. J. Neurol. Sci., 113, 222-229.
100. Morovvati, S., Nakagawa, M., Sato, Y., Hamada, K., Higuchi, I. and Osame, M. (2002) Phenotypes and mitochondrial DNA substitutions in families with A3243G mutation. Acta Neurol. Scand., 106, 104-108.
101. Olsson, C., Zethelius, B., Lagerstrom-Fermer, M., Asplund, J., Berne, C. and Landegren, U. (1998) Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum. Mutat., 12, 52-58.
102. Onishi, H., Hanihara, T., Sugiyama, N. et al. (1998) Pancreatic exocrine dysfunction associated with mitochondrial tRNA (Leu)(UUR) mutation. J Med Genet, 35, 255-257.
103. Rusanen, H., Majamaa, K., Tolonen, U., Remes, A.M., Myllyla, R. and Hassinen, I.E. (1995) Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology, 45, 1188-1192.
104. Vilarinho, L., Santorelli, F.M., Rosas, M.J., Tavares, C., Melo-Pires, M. and DiMauro, S. (1997) The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J. Med. Genet., 34, 607-609.
105. Wilichowski, E., Korenke, G.C., Ruitenbeek, W. et al. (1998) Pyruvate dehydrogenase complex deficiency and altered respiratory chain function in a patient with Kearns-Sayre/MELAS overlap syndrome and A3243G mtDNA mutation. J. Neurol. Sci., 157, 206-213.